Does anyone recall the shareholder meeting from last fall when NP read a letter from the FDA that basically stated they wanted nothing more than to approve Leronlimab? Well here we sit with a killer virus that the FDA knows our drug is effective with and safe. Oh well I guess they meant approve for HIV... they better act and fast. I hope NP reminds them of that letter...